Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 2/20 | 0.62 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | CA12 | O43570 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | GLA | P06280 | 1/20 | 0.46 |
| ▸ | CA3 | P07451 | 1/20 | 0.46 |
| ▸ | CA4 | P22748 | 1/20 | 0.46 |
| ▸ | CA9 | Q16790 | 1/20 | 0.46 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.46 |
| ▸ | SLC1A2 | P43004 | 4/20 | 0.44 |
| ▸ | SLC1A3 | P43003 | 3/20 | 0.44 |
| ▸ | SLC1A1 | P43005 | 3/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Valine SCHEMBL5479272 | 1.00 | SLC7A5 (0.62) | SLC7A5LMNAHIF1AKDM4ETDP1 | |
| Valine SCHEMBL1424875 | 0.91 | SLC7A5 (0.68) | SLC7A5LMNAHIF1AKDM4ETDP1 | |
| Biphenyl SCHEMBL2494151 | 0.85 | SLC7A5 (0.65) | SLC7A5SLC1A2SLC1A3SLC1A1CYP1A2 | |
| Biphenyl SCHEMBL27824248 | 0.85 | SLC7A5 (0.65) | SLC7A5SLC1A2SLC1A3SLC1A1CYP1A2 | |
| Phenol SCHEMBL2786799 | 0.85 | CA12 (0.52) | SLC7A5LMNAHIF1AKDM4ETDP1 | |
| Phenol SCHEMBL2786796 | 0.85 | CA12 (0.52) | SLC7A5LMNAHIF1AKDM4ETDP1 | |
| Valine SCHEMBL4582565 | 0.84 | SLC7A5 (0.88) | SLC7A5LMNATDP1SLC1A2SLC1A3 | |
| Valine SCHEMBL28052598 | 0.84 | SLC7A5 (0.88) | SLC7A5LMNATDP1SLC1A2SLC1A3 | |
| Valine SCHEMBL5324319 | 0.84 | SLC7A5 (0.58) | SLC7A5LMNAHIF1ATDP1CA3 | |
| Valine SCHEMBL6639200 | 0.83 | SLC7A5 (0.62) | SLC7A5SLC1A2SLC1A3SLC1A1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 128 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1177812-C | Process for preparing O-phenoxyalkylhydroxylamine or O-phenoxyalkyloxime isomer mixtures | �����ɷ� | 2004-12-01 | — | — | CN | claimed |
| CN-1381522-A | Stable middle voltoge and high voltage cable insulation composition | CIBA SC HOLDING AG (CH) | 2002-11-27 | — | — | CN | claimed |
| EP-0788475-B1 | PROCESS FOR PRODUCING ISOMER MIXTURES FROM O-PHENOXYALKYLHYDROXYL AMINES OR O-PHENOXYALKYLOXIMES | BASF AG (DE) | 1999-10-20 | — | — | EP | claimed |
| US-5739402-A | Process for the preparation of mixtures of isomers of O-phenoxy-alkylhydroxylamines or O-phenoxyalkyloximes | BASF AKTIENGESELLSCHAFT (DE) | 1998-04-14 | — | — | US | claimed |
| EP-0788475-A1 | PROCESS FOR PRODUCING ISOMER MIXTURES FROM O-PHENOXYALKYLHYDROXYL AMINES OR O-PHENOXYALKYLOXIMES | BASF AKTIENGESELLSCHAFT (DE) | 1997-08-13 | — | — | EP | claimed |
| CN-1150418-A | Process for producing isomer mixtures from 0-phenoxyalkylhydroxyl amines or 0-phenoxyalkyloximes | BASF AG (DE) | 1997-05-21 | — | — | CN | claimed |
| WO-1995030648-A1 | PROCESS FOR PRODUCING ISOMER MIXTURES FROM O-PHENOXYALKYLHYDROXYL AMINES OR O-PHENOXYALKYLOXIMES | BASF AKTIENGESELLSCHAFT (DE) | 1995-11-16 | — | — | WO | claimed |
| CN-118221656-A | Compounds useful for the treatment of gastrointestinal disorders | 阿德利克斯股份有限公司 | 2024-06-21 | — | — | CN | disclosed |
| CN-117871734-A | Characterization method of lignin in environmental sample | 西北农林科技大学 | 2024-04-12 | — | — | CN | disclosed |
| CN-110267944-B | Compounds useful for the treatment of gastrointestinal disorders | 阿德利克斯股份有限公司 | 2024-03-08 | — | — | CN | disclosed |
| US-11242337-B2 | Compounds useful for treating gastrointestinal tract disorders | ARDELYX, INC. (US) | 2022-02-08 | — | — | US | disclosed |
| US-11130740-B2 | Substituted 2,3-dihydro-1H-indene analogs and methods using same | ARBUTUS BIOPHARMA CORPORATION (CA) | 2021-09-28 | — | — | US | disclosed |
| WO-2020255021-A1 | COMBINATION OF HEPATITIS B VIRUS (HBV) VACCINES AND SMALL MOLECULE PDL1 OR PD1 INHIBITOR | Janssen Sciences Ireland Unlimited Company (IE) | 2020-12-24 | — | — | WO | disclosed |
| EP-0099177-A1 | Halogenophenyl glyceride esters | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1984-01-25 | — | — | EP | disclosed |
| US-4410675-A | EPOXY RESINS, ALDEHYDE, MERCAPTOCARBOXYLIC ACID OR SULFUROUS ACID, PROTECTIVE COATINGS | CIBA-GEIGY CORPORATION (US) | 1983-10-18 | — | — | US | disclosed |
| US-4374258-A | PHOTOSTABILITY; HEAT AND OXIDATION RESISTANCE; ADDITION POLYMERS | BASF AKTIENGESELLSCHAFT (DE) | 1983-02-15 | — | — | US | disclosed |
| US-4362853-A | MANNICH REACTION OF BISPHENOL EPOXY RESIN WITH ALDEHYDE AND AMINO ACID | CIBA-GEIGY CORPORATION (US) | 1982-12-07 | — | — | US | disclosed |
| EP-0065668-A2 | Urea derivatives, their preparation and use | CELAMERCK GmbH & Co. KG (DE) | 1982-12-01 | — | — | EP | disclosed |
| EP-0051561-A1 | Resinlike salts, their preparation and their use in coatings | CIBA-GEIGY AG (CH) | 1982-05-12 | — | — | EP | disclosed |
| US-4005150-A | Phenyl ethers having juvenile hormone activity | CESKOSLOVENSKA AKADEMIE VED (CS) | 1977-01-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11242337-B2 | Compounds useful for treating gastrointestinal tract disorders | SLC10A2, FABP2, SLC10A1 | SLC7A5 518/4885LMNA 4122/4885HIF1A 3759/4885 |
| US-11130740-B2 | Substituted 2,3-dihydro-1H-indene analogs and methods using same | HAVCR2, DHPS, IDH3A | SLC7A5 3029/4885LMNA 1324/4885HIF1A 901/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.